US-BASED population health expert, RaeAnn Grossman, has been appointed to the Board of MedAdvisor (MDR) as a non-executive director, by the medtech firm's largest shareholder, Cotiviti.
In a statement to the Australian Securities Exchange, MDR Chair, Chris Ridd, said that Grossman would "add significant insight, interest and alignment" to the Board, as it grows its US business.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Feb 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Feb 22
